Revisiting the cardiovascular risk of hydroxychloroquine in RA

Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pers, Yves-Marie, Padern, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525224/
https://www.ncbi.nlm.nih.gov/pubmed/32999492
http://dx.doi.org/10.1038/s41584-020-00521-x
Descripción
Sumario:Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoid arthritis.

Ejemplares similares